Pradaxa Reversal Agent Approved

November 3, 2015

In 2010, the FDA approved the prescription blood-thinning drug Pradaxa (dabigatran) to prevent stroke and systemic blood clots in patients with atrial fibrillation, as well as for the treatment and prevention of deep venous thrombosis and pulmonary embolism. On October 16, 2015, the FDA granted acc[...]

Continue Reading

14 Indicted In Connection With NECC Fungal Meningitis Outbreak

December 20, 2014

According to a press release issued by the U.S. Department of Justice, a 131-count criminal indictment was unsealed on December 17, 2014 in connection with the 2012 nationwide fungal meningitis outbreak traced back to the New England Compounding Center (“NECC”). The owner/head pharmac[...]

Continue Reading

Pharmaceutical Company Recalls Empty Gabapentin Capsules

December 5, 2014

On November 21, 2014, the pharmaceutical company Aurobindo Pharma USA announced its voluntary recall of a particular lot (GESB14011-A, expiration date 12/2015) of its Gabapentin Capsules, USP 300 mg 100-count bottles because the lot has been found to contain some empty capsules. The capsules have[...]

Continue Reading